J A Cramer

Summary

Publications

  1. doi request reprint Healthcare utilization and costs in children with stable and uncontrolled epilepsy
    Joyce A Cramer
    Yale University School of Medicine, New Haven, CT, USA Consultant, Houston, TX, USA Electronic address
    Epilepsy Behav 32:135-41. 2014
  2. doi request reprint Determining minimally important change thresholds for the Seizure Severity Questionnaire (SSQ)
    Joyce A Cramer
    Houston, TX, USA Electronic address
    Epilepsy Behav 31:286-90. 2014
  3. doi request reprint Healthcare utilization and costs in adults with stable and uncontrolled epilepsy
    Joyce A Cramer
    Yale University School of Medicine, New Haven, CT, USA Electronic address
    Epilepsy Behav 31:356-62. 2014
  4. doi request reprint Indirect comparison of clobazam and other therapies for Lennox-Gastaut syndrome
    J A Cramer
    Acta Neurol Scand 128:91-9. 2013

Detail Information

Publications4

  1. doi request reprint Healthcare utilization and costs in children with stable and uncontrolled epilepsy
    Joyce A Cramer
    Yale University School of Medicine, New Haven, CT, USA Consultant, Houston, TX, USA Electronic address
    Epilepsy Behav 32:135-41. 2014
    ..We compared annual healthcare utilization and costs between children (<12years old) with stable and uncontrolled epilepsy treated with antiepileptic drugs (AEDs)...
  2. doi request reprint Determining minimally important change thresholds for the Seizure Severity Questionnaire (SSQ)
    Joyce A Cramer
    Houston, TX, USA Electronic address
    Epilepsy Behav 31:286-90. 2014
    ..The calculated MIC thresholds (range: 0.34 to 0.50) suggest that a 0.48-point change in the SSQ total score reflects a clinically meaningful change in seizure severity from the patients' perspective. ..
  3. doi request reprint Healthcare utilization and costs in adults with stable and uncontrolled epilepsy
    Joyce A Cramer
    Yale University School of Medicine, New Haven, CT, USA Electronic address
    Epilepsy Behav 31:356-62. 2014
    ..Epilepsy-related costs accounted for <50% of the total costs, suggesting that comorbid conditions and/or underidentification of utilization may substantially contribute to costs. ..
  4. doi request reprint Indirect comparison of clobazam and other therapies for Lennox-Gastaut syndrome
    J A Cramer
    Acta Neurol Scand 128:91-9. 2013
    ..We conducted indirect comparisons of the relative efficacies of clobazam, felbamate, lamotrigine, topiramate, and rufinamide as adjunctive treatments for LGS...